𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Exploring complement activation to develop biomarkers for systemic lupus erythematosus

✍ Scribed by George C. Tsokos

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
105 KB
Volume
50
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum free light chains as biomarkers fo
Serum free light chains as biomarkers for systemic lupus erythematosus disease activity
✍ Rohit Aggarwal; Winston Sequeira; Rediet Kokebie; Rachel A. Mikolaitis; Lewis Fo πŸ“‚ Article πŸ“… 2011 πŸ› Wiley (John Wiley & Sons) 🌐 English βš– 267 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate serum free light chains (FLC) as a putative biomarker of systemic lupus erythematosus (SLE) activity. ## Methods Seventy‐five SLE patients and 41 age‐ and sex‐matched rheumatoid arthritis (RA) controls were enrolled. Disease activity was assessed using the Sa

Sialic acid–binding Ig-like lectin 1 exp
Sialic acid–binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus
✍ Robert Biesen; Cemal Demir; Fidan Barkhudarova; Joachim R. GrΓΌn; Marta Steinbric πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 257 KB πŸ‘ 2 views

## Abstract ## Objective Type I interferon (IFN) plays a pivotal role in the pathogenesis of systemic lupus erythematosus (SLE) and is therefore considered a potential therapeutic target. This study was undertaken to establish a feasible biomarker for IFN effects with respect to disease activity a